Viewing Study NCT07379268


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-31 @ 12:25 AM
Study NCT ID: NCT07379268
Status: RECRUITING
Last Update Posted: 2026-01-30
First Post: 2026-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
Sponsor: Qilu Hospital of Shandong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module